Skip to main content

Part of the book series: Issues in Clinical Child Psychology ((ICCP))

  • 537 Accesses

Abstract

Although there is a paucity of empirically based studies on the use of psychotropic drugs in the treatment of childhood disorders, medication is often considered an integral part of a treatment plan for children with psychiatric and behavioral disorders (Olfson, Pincus, & Sabshin, 1994). However, it is important to remember that medication is typically used as only one component of a broad therapeutic approach to alleviate psychiatric symptoms in children. For psychiatric problems, such as anxiety or depression, medication provides symptomatic relief, allowing the child to function more fully at school and at home. In general, medication should be used to improve the child’s general functioning and quality of life rather than strictly for reducing undesirable behaviors or symptoms (Singh, 1995). Further, although medication may relieve the child’s symptoms of psychiatric illness, it does not remove vulnerability to its recurrence because the environmental and constitutional stressors that gave rise to the illness are not affected by the medication.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Achenbach, T. M. (1991). Manual for the CBCL/4-18 and Profile. Burlington: Department of Psychiatry, University of Vermont.

    Google Scholar 

  • Alessi, N., Naylor, M. W., Ghaziuddin, M., & Zubieta, J. K. (1994). Update on lithium carbonate therapy in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 291–304.

    Article  PubMed  Google Scholar 

  • Aman, M. G. (1993). Monitoring and measuring drug effects. II. Behavioral, emotional, and cognitive effects. In J. S. Werry & M. G. Aman (Eds.), Practitioner’s guide to psychoactive drugs for children and adolescents (pp. 99–159). New York: Plenum Press.

    Chapter  Google Scholar 

  • Baldessarini, R., & Frankenburg, F. R. (1991). Clozapine: A novel antipsychotic agent. New England Journal of Medicine, 324, 746–754.

    Article  PubMed  Google Scholar 

  • Ballenger, J. C., & Post, R. M. (1980). Carbamazepine in manic-depressive illness: A new treatment. American Journal of Psychiatry, 137, 782–790.

    PubMed  Google Scholar 

  • Barkley, R. A. (1990). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford Press.

    Google Scholar 

  • Barkley, R. A., DuPaul, G. J., & Costello, A. (1993). Stimulants. In J. S. Werry & M. G. Aman (Eds.), Practitioner’s guide to psychoactive drugs for children and adolescents (pp. 205–237). New York: Plenum Press.

    Chapter  Google Scholar 

  • Carpenter, R. O., & Vining, E. P. G. (1993). Antiepileptics (anticonvulsants). In J. S. Werry & M. G. Aman (Eds.), Practitioner’s guide to psychoactive drugs for children and adolescents (pp. 321–346). New York: Plenum Press.

    Chapter  Google Scholar 

  • Clein, P. D., & Riddle, M. A. (1995). Pharmacokinetics in children and adolescents. Child and Adolescent Psychiatric Clinics of North America, 4, 59–75.

    Google Scholar 

  • Conners, C. K. (1990). Conners’ Rating Scales Manual, Conners’ Teacher Rating Scales, Conners Parent Rating Scales. Instruments for use with children and adolescents. North Tonawanda, NY: Multi-Health Systems.

    Google Scholar 

  • Dingemanse, J., Danhof, M., & Breimer, D. D. (1988). Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: An overview. Pharmacology and Therapeutics, 38, 1–52.

    Article  PubMed  Google Scholar 

  • Ellis, C. R., Singh, Y. N., & Singh, N. N. (1997). Use of behavior-modifying drugs. In N. N. Singh (Ed.). Prevention and treatment of severe behavior problems: Models and methods in developmental disabilities (pp. 149–176). Monterey, CA: Brooks/Cole.

    Google Scholar 

  • Evans, R. W., Clay, T. H., & Gualtieri, C. T. (1987). Carbamazepine in pediatric psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 2–8.

    Article  PubMed  Google Scholar 

  • Evans, W. E., Schentag, J. J., & Jusko, W. J. (1986). Applied pharmacokinetic principles of therapeutic drug monitoring (2nd ed. ) San Francisco: Applied Therapeutics.

    Google Scholar 

  • Green, W. H. (1995). Child and adolescent clinical psychopharmacology (2nd ed.). Baltimore: Williams & Wilkins.

    Google Scholar 

  • Greenblatt, D. J., & Shader, R. I. (1987). Introduction: Pharmacokinetics in clinical psychiatry and psychopharmacology. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (p. 1339). New York: Raven Press.

    Google Scholar 

  • Handen, B. L., Feldman, H., Gosling, A., Breaux, A., & McAuliffe, S. (1991). Adverse side effects of Ritalin among mentally retarded children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 241–245.

    Article  PubMed  Google Scholar 

  • Institute of Medicine (1990). Research on children and adolescents with mental, behavioral, and developmental disorders. Bethesda: National Institute of Mental Health.

    Google Scholar 

  • Janicak, P. G., Davis, J. M., Preskorn, S. H., & Ayd, F. J. (1993). Principles and practice of psychopharmacology. Baltimore: Williams & Wilkins.

    Google Scholar 

  • Kalow, W. (1990). Pharmacogenetics: Past and future. Life Sciences, 47, 1385–1397.

    Article  PubMed  Google Scholar 

  • Kutcher, S. P. (1997). Child and adolescent psychopharmacology. Philadelphia: Saunders.

    Google Scholar 

  • Lieberman, J. A., Kane, J. M., & Johns, C. A. (1989). Clozapine: Guidelines for clinical management. Journal of Clinical Psychiatry, 50, 329–338.

    PubMed  Google Scholar 

  • McElroy, S. L., Keck, P., & Pope, H. G. (1987). Sodium valproate: Its use in primary psychiatric disorders. Journal of Clinical Psychopharmacology, 7, 16–24.

    PubMed  Google Scholar 

  • Moerman, D. E. (1979). Anthropology of symbolic healing. Currents in Anthropology, 20, 59–80.

    Article  Google Scholar 

  • Nebert, D. W, & Weber, W. W. (1990). Pharmacogenetics. In W. B. Pratt & P. Taylor (Eds.), Principles of drug action (pp. 469–531). New York: Churchill Livingstone.

    Google Scholar 

  • Olfson, M., Pincus, H. A., & Sabshin, M. (1994). Pharmacotherapy in outpatient psychiatric practice. American Journal of Psychiatry, 151, 580–585.

    PubMed  Google Scholar 

  • Paxton, J. W., & Dragunow, M. (1993). Pharmacology. In J. S. Werry & M. G. Aman (Eds.), Practitioner’s guide to psychoactive drugs for children and adolescents (pp. 23–55). New York: Plenum Press.

    Chapter  Google Scholar 

  • Popper, C. W. (1995). Balancing knowledge and judgement: A clinician looks at new developments in child and adolescent psychopharmacology. Child and Adolescent Psychiatric Clinics of North America, 4, 483–513.

    Google Scholar 

  • Post, R. M. (1987). Mechanisms of action of carbamazepine and related anticonvulsants in affective illness. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 567–594). New York: Raven Press.

    Google Scholar 

  • Remschmidt, H. (1976). The psychotropic effects of carbamazepine in non-epileptic patients, with particular reference to problems posed by clinical studies in children with behavioral disorders. In W. Birkmayer (Ed.), Epileptic seizures, behavior, pain (pp. 253–258). Bern: Huber.

    Google Scholar 

  • Riddle, M. A., Nelson, J. C., Kleinman, C. S., Rasmusson., A., Leckman, J. F., King, R. A., & Cohen, D. J. (1991). Sudden death in children receiving Norpramin: A review of three reported cases and commentary. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 104–108.

    Article  PubMed  Google Scholar 

  • Singh, N. N. (1995). Moving beyond institutional care for individuals with developmental disabilities. Journal of Child and Family Studies, 4, 129–145.

    Article  Google Scholar 

  • Singh, N. N., & Aman, M. G. (1990). Ecobehavioral assessment of pharmacotherapy. In S. Schroeder (Ed.), Ecobehavioral analysis in developmental disabilities (pp. 182–200). Berlin: Springer-Verlag.

    Chapter  Google Scholar 

  • Singh, N. N., & Ellis, C. R. (1998). Pharmacological therapies. In A. S. Bellack & M. Hersen (Ser. Eds.), T. Ollendick (Vol. Ed.), Comprehensive clinical psychology: Vol. 4. Children and adolescents: Clinical formulation and treatment (pp. 267–293). New York: Elsevier Science.

    Google Scholar 

  • Singh, N. N., Ellis, C. R., & Axtell, P. K. (1998). Psychopharmacology and steady-state behavior. In J. K. Luiselli & M. J. Cameron (Eds.), Beyond consequences: Antecedent control approaches for the behavioral support of persons with developmental disabilities (pp. 137–162).Baltimore: Paul H. Brookes.

    Google Scholar 

  • Singh, N. N., Parmelee, D. X., Sood, A., & Katz, R. C. (1993). Collaboration of disciplines. In J. L. Matson (Ed.), Handbook of hyperactivity in children (pp. 305–322). Boston: Allyn & Bacon.

    Google Scholar 

  • Sood, A., & Singh, N. N. (1996). Diagnostic instruments. In D. X. Parmelee (Ed.), Child and adolescent psychiatry (pp. 19–31). St. Louis: Mosby.

    Google Scholar 

  • Sprague, R. L., & Gadow, K. D. (1976). The role of the teacher in drug treatment. School Reviews, 85, 109–140.

    Article  Google Scholar 

  • Towbin, K. E. (1995). Evaluation, establishing the treatment alliance, and informed consent. Child and Adolescent Psychiatric Clinics of North America, 4, 1–14.

    Google Scholar 

  • Viesselman, J. O, Yaylayan, S., Weiler, E. B., & Weller, R. A. (1993). Antidysthymic drugs (antidepressants and antimanics). In J. S. Werry & M. G. Aman (Eds.), Practitioner’s guide to psychoactive drugs for children and adolescents (pp. 239–268). New York: Plenum Press.

    Chapter  Google Scholar 

  • Walkup, J. T. (1995). Clinical decision making in child and adolescent psychopharmacology. Child and Adolescent Psychiatric Clinics of North America, 4, 23–40.

    Google Scholar 

  • Zhou, H. H., Koshakji, R. P., Silberstein, D. J., Wilkinson, G. P., & Wood, A. J. (1989). Racial differences in drug response: Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. New England Journal of Medicine, 320, 565–570.

    Article  PubMed  Google Scholar 

  • Zorumski, C. F., & Isenberg, K. E. (1991). Insights into the structure and function of GABA-benzodiazepine receptors: Ion channels and psychiatry. American Journal of Psychiatry, 148, 162–163.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ellis, C.R., Singh, N.N. (1999). Psychopharmacological Approaches. In: Russ, S.W., Ollendick, T.H. (eds) Handbook of Psychotherapies with Children and Families. Issues in Clinical Child Psychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4755-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4755-6_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7156-4

  • Online ISBN: 978-1-4615-4755-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics